125 related articles for article (PubMed ID: 2508794)
1. Antimalarial effect of HBED and other phenolic and catecholic iron chelators.
Yinnon AM; Theanacho EN; Grady RW; Spira DT; Hershko C
Blood; 1989 Nov; 74(6):2166-71. PubMed ID: 2508794
[TBL] [Abstract][Full Text] [Related]
2. Phenolic ethylenediamine derivatives: a study of orally effective iron chelators.
Hershko C; Grady RW; Link G
J Lab Clin Med; 1984 Mar; 103(3):337-46. PubMed ID: 6699459
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters.
Hershko C; Grady RW; Link G
Haematologia (Budap); 1984; 17(1):25-33. PubMed ID: 6427069
[TBL] [Abstract][Full Text] [Related]
4. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.
Hershko C; Theanacho EN; Spira DT; Peter HH; Dobbin P; Hider RC
Blood; 1991 Feb; 77(3):637-43. PubMed ID: 1991172
[TBL] [Abstract][Full Text] [Related]
5. HBED: A potential alternative to deferoxamine for iron-chelating therapy.
Bergeron RJ; Wiegand J; Brittenham GM
Blood; 1998 Feb; 91(4):1446-52. PubMed ID: 9454776
[TBL] [Abstract][Full Text] [Related]
6. HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapy.
Bergeron RJ; Wiegand J; Brittenham GM
Blood; 1999 Jan; 93(1):370-5. PubMed ID: 9864183
[TBL] [Abstract][Full Text] [Related]
7. Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
Lau EH; Cerny EA; Wright BJ; Rahman YE
J Lab Clin Med; 1983 May; 101(5):806-16. PubMed ID: 6403640
[TBL] [Abstract][Full Text] [Related]
8. Novel double prodrugs of the iron chelator N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED): Synthesis, characterization, and investigation of activation by chemical hydrolysis and oxidation.
Thiele NA; Abboud KA; Sloan KB
Eur J Med Chem; 2016 Aug; 118():193-207. PubMed ID: 27128183
[TBL] [Abstract][Full Text] [Related]
9. Deferoxamine inhibition of malaria is independent of host iron status.
Hershko C; Peto TE
J Exp Med; 1988 Jul; 168(1):375-87. PubMed ID: 3294334
[TBL] [Abstract][Full Text] [Related]
10. UV and fluorescence spectral changes induced by neodymium binding of N,N'-ethylenebis[2-(o-hydroxyphenolic)glycine] and N,N'-di(2-hydroxybenzyl)ethylenediamine-N,N' diacetic acid.
Wang Z; Yang B
Spectrochim Acta A Mol Biomol Spectrosc; 2006 Nov; 65(3-4):946-9. PubMed ID: 16684618
[TBL] [Abstract][Full Text] [Related]
11. The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.
Hershko C; Gordeuk VR; Thuma PE; Theanacho EN; Spira DT; Hider RC; Peto TE; Brittenham GM
J Inorg Biochem; 1992 Aug 15-Sep; 47(3-4):267-77. PubMed ID: 1431886
[TBL] [Abstract][Full Text] [Related]
12. HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning.
Bergeron RJ; Wiegand J; Brittenham GM
Blood; 2002 Apr; 99(8):3019-26. PubMed ID: 11929795
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Fe-HBED and Fe-EHPG as hepatobiliary MR contrast agents.
Hoener B; Engelstad BL; Ramos EC; Macapinlac HA; Price DC; Johnson TR; White DL
J Magn Reson Imaging; 1991; 1(3):357-62. PubMed ID: 1802149
[TBL] [Abstract][Full Text] [Related]
14. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators.
Loyevsky M; John C; Dickens B; Hu V; Miller JH; Gordeuk VR
Mol Biochem Parasitol; 1999 Jun; 101(1-2):43-59. PubMed ID: 10413042
[TBL] [Abstract][Full Text] [Related]
15. Chemical evaluation of HBED/Fe(3+) and the novel HJB/Fe(3+) chelates as fertilizers to alleviate iron chlorosis.
López-Rayo S; Hernández D; Lucena JJ
J Agric Food Chem; 2009 Sep; 57(18):8504-13. PubMed ID: 19689133
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of a novel iron chelator (HBED; (N,N'-Di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid)) in equine (Equus caballus) as a model for black rhinoceros (Diceros bicornis).
Sullivan KE; Lavin SR; Livingston S; Knutson M; Valdes EV; Warren LK
J Anim Physiol Anim Nutr (Berl); 2022 Sep; 106(5):1107-1117. PubMed ID: 35894091
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional antioxidant activity of HBED iron chelator.
Samuni AM; Afeworki M; Stein W; Yordanov AT; DeGraff W; Krishna MC; Mitchell JB; Brechbiel MW
Free Radic Biol Med; 2001 Jan; 30(2):170-7. PubMed ID: 11163534
[TBL] [Abstract][Full Text] [Related]
18. Assessment of potential aluminum chelators in an octanol/aqueous system and in the aluminum-loaded rabbit.
Yokel RA; Kostenbauder HB
Toxicol Appl Pharmacol; 1987 Nov; 91(2):281-94. PubMed ID: 3672527
[TBL] [Abstract][Full Text] [Related]
19. A Double Prodrug with Improved Membrane Permeability over the Parent Chelator HBED Provides Superior Cytoprotection against Hydrogen Peroxide.
Thiele NA; Sloan KB
ChemMedChem; 2016 Aug; 11(15):1596-9. PubMed ID: 27440560
[TBL] [Abstract][Full Text] [Related]
20. Spectral studies on the interaction of yttrium ion with the ligands of phenolic groups: N,N'-Ethylenebis[2-(o-hydroxyphenolic)glycine] and N,N'-di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid.
Duan L; Zhao YQ; Yang BS
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Sep; 68(1):165-8. PubMed ID: 17267267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]